| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.28B | +18.8% |
| Cost of Revenue | $2.00B | +31.6% |
| Gross Profit | $286.1M | -29.2% |
| R&D Expense | $196.3M | +25.2% |
| SG&A Expense | $254.6M | +16.6% |
| Operating Income | -$363.3M | -230.4% |
| Interest Expense | $17.7M | +50.9% |
| Income Tax | $126K | +102.1% |
| Net Income | -$321.1M | -193.0% |
| EPS (Basic) | -$2.99 | -167.0% |
| EPS (Diluted) | -$2.99 | -167.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $239.8M | -59.4% |
| Short-term Investments | $122.3M | +262.4% |
| Accounts Receivable | $54.9M | -21.1% |
| Inventory | $114.3M | -68.1% |
| Current Assets | $776.5M | -37.7% |
| Total Assets | $1.57B | -22.1% |
| Current Liabilities | $354.6M | -11.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $40.5M | +113.4% |
| Capital Expenditures | $21.5M | -21.7% |
| Investing Cash Flow | -$184.3M | +68.0% |
| Financing Cash Flow | -$332.1M | -151.1% |
| Free Cash Flow | $19.0M | +105.8% |
| Total Liabilities |
| $1.47B |
| -12.1% |
| Stockholders' Equity | $64.0M | -79.4% |